Market Cap 8.51M
Revenue (ttm) 500,000.00
Net Income (ttm) -39.83M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -7,966.00%
Debt to Equity Ratio 0.00
Volume 1,482,900
Avg Vol 2,384,206
Day's Range N/A - N/A
Shares Out 25.47M
Stochastic %K 20%
Beta 1.76
Analysts Sell
Price Target $2.00

Company Profile

VYNE Therapeutics Inc., a clinical-stage biopharmaceutical company, focuses on developing therapies to treat chronic inflammatory and immune-mediated conditions. The company's lead program is repibresib gel (VYN201), a topically administered small molecule pan-bromodomain and extra-terminal (BET) inhibitor soft drug to address diseases involving multiple and diverse inflammatory cell signaling pathways with low systemic exposure. It also develops VYN202, a BD2-selective oral small molecule BET i...

Industry: Biotechnology
Sector: Healthcare
Phone: 800 775 7936
Address:
685 Route 202/206 N, Suite 301, Bridgewater, United States
joe77w
joe77w Aug. 23 at 7:42 PM
$VYNE just my math, do your dd before investing your money. I would buy below 30 cents. I am not ruling out trial resume at all. The best option for commons would be Bod to opt for strategic alternatives review. Last 10Q clearly stated 25 mln shares out standing as of August but of you read INCOME STATEMENT Os 42.7 mln due to prefunded warrants out standing
0 · Reply
joe77w
joe77w Aug. 23 at 7:38 PM
$VYNE according to me, after reading last 10Q with figures updated as of June 30, in the worst case scenario cash and cash equivalents / book value at year end would not be less than 30 mln USD while fully diluted basis 43 mln shares or 70 cents per share. I am assuming a reduced cash burn due to lower R&D activities.
0 · Reply
NEWYORKSILVERKING
NEWYORKSILVERKING Aug. 23 at 4:34 PM
$VYNE Isn`t fair value net of debt and wind down cost closer to 1 dollar ???
0 · Reply
NEWYORKSILVERKING
NEWYORKSILVERKING Aug. 23 at 4:32 PM
$VYNE warrants exercisable for up to 5,287,413 Vyne Therapeutics ...(VYNE) has approximately 16.66 million shares outstanding..Why are folks figuring in the full warrant number for fair value when the filing clearly stated it`s capped at 9.99% of the outstanding share count??
0 · Reply
NEWYORKSILVERKING
NEWYORKSILVERKING Aug. 23 at 4:19 PM
$VYNE This Schedule 13G amendment is being filed to disclose a change in the mix of security types owned. As of June 30, 2025, Eventide is the beneficial owner of common stock of the Issuer ("Common Stock") issuable upon the exercise of pre-funded warrants (the "Warrants") as the investment adviser to Eventide Healthcare Innovation Fund I LP, a private fund (the "Fund"); provided that the Warrants may not be exercised if such exercise would cause the holder to beneficially own in excess of 9.99% of the number of shares of the Issuer's Common Stock
0 · Reply
joe77w
joe77w Aug. 23 at 7:39 AM
$VYNE worth at least 60/65 cents based on net cash, way undervalued imo
1 · Reply
nonamestockz
nonamestockz Aug. 23 at 6:35 AM
$VYNE will be big like AQB
0 · Reply
Komba
Komba Aug. 22 at 7:16 PM
$VYNE found bottom here. Buy. Big bounce ahead:)
0 · Reply
Duskfall
Duskfall Aug. 22 at 7:03 PM
INCOMING 📈✅ $VYNE $0.50+ $INTS $0.42+ $OLB $3+ $IVF $1.75+
0 · Reply
Duskfall
Duskfall Aug. 22 at 5:07 PM
$VYNE 💪
0 · Reply
Latest News on VYNE
FDA Puts VYNE Therapeutics Early-Stage Psoriasis Study On Hold

Apr 25, 2025, 11:55 AM EDT - 4 months ago

FDA Puts VYNE Therapeutics Early-Stage Psoriasis Study On Hold


VYNE Therapeutics Provides Update on VYN202 Program

Apr 25, 2025, 8:00 AM EDT - 4 months ago

VYNE Therapeutics Provides Update on VYN202 Program


VYNE Therapeutics to Participate in March Investor Conferences

Feb 20, 2025, 8:00 AM EST - 6 months ago

VYNE Therapeutics to Participate in March Investor Conferences


Menlo Ventures Raises $1.35B for AI Investments

Nov 16, 2023, 4:03 PM EST - 1 year ago

Menlo Ventures Raises $1.35B for AI Investments


VYNE Therapeutics Announces Private Placement of $88 Million

Oct 30, 2023, 7:05 AM EDT - 1 year ago

VYNE Therapeutics Announces Private Placement of $88 Million


VYNE Therapeutics to Attend BIO International Convention

May 18, 2023, 8:00 AM EDT - 2 years ago

VYNE Therapeutics to Attend BIO International Convention


VYNE Therapeutics Announces Reverse Stock Split

Feb 10, 2023, 8:00 AM EST - 2 years ago

VYNE Therapeutics Announces Reverse Stock Split


joe77w
joe77w Aug. 23 at 7:42 PM
$VYNE just my math, do your dd before investing your money. I would buy below 30 cents. I am not ruling out trial resume at all. The best option for commons would be Bod to opt for strategic alternatives review. Last 10Q clearly stated 25 mln shares out standing as of August but of you read INCOME STATEMENT Os 42.7 mln due to prefunded warrants out standing
0 · Reply
joe77w
joe77w Aug. 23 at 7:38 PM
$VYNE according to me, after reading last 10Q with figures updated as of June 30, in the worst case scenario cash and cash equivalents / book value at year end would not be less than 30 mln USD while fully diluted basis 43 mln shares or 70 cents per share. I am assuming a reduced cash burn due to lower R&D activities.
0 · Reply
NEWYORKSILVERKING
NEWYORKSILVERKING Aug. 23 at 4:34 PM
$VYNE Isn`t fair value net of debt and wind down cost closer to 1 dollar ???
0 · Reply
NEWYORKSILVERKING
NEWYORKSILVERKING Aug. 23 at 4:32 PM
$VYNE warrants exercisable for up to 5,287,413 Vyne Therapeutics ...(VYNE) has approximately 16.66 million shares outstanding..Why are folks figuring in the full warrant number for fair value when the filing clearly stated it`s capped at 9.99% of the outstanding share count??
0 · Reply
NEWYORKSILVERKING
NEWYORKSILVERKING Aug. 23 at 4:19 PM
$VYNE This Schedule 13G amendment is being filed to disclose a change in the mix of security types owned. As of June 30, 2025, Eventide is the beneficial owner of common stock of the Issuer ("Common Stock") issuable upon the exercise of pre-funded warrants (the "Warrants") as the investment adviser to Eventide Healthcare Innovation Fund I LP, a private fund (the "Fund"); provided that the Warrants may not be exercised if such exercise would cause the holder to beneficially own in excess of 9.99% of the number of shares of the Issuer's Common Stock
0 · Reply
joe77w
joe77w Aug. 23 at 7:39 AM
$VYNE worth at least 60/65 cents based on net cash, way undervalued imo
1 · Reply
nonamestockz
nonamestockz Aug. 23 at 6:35 AM
$VYNE will be big like AQB
0 · Reply
Komba
Komba Aug. 22 at 7:16 PM
$VYNE found bottom here. Buy. Big bounce ahead:)
0 · Reply
Duskfall
Duskfall Aug. 22 at 7:03 PM
INCOMING 📈✅ $VYNE $0.50+ $INTS $0.42+ $OLB $3+ $IVF $1.75+
0 · Reply
Duskfall
Duskfall Aug. 22 at 5:07 PM
$VYNE 💪
0 · Reply
realtorstud
realtorstud Aug. 22 at 4:37 PM
$VYNE This should be up more today? IMO. Is this setting up for a reverse split? I have an average to small position but hate todays action. Anybody?
1 · Reply
nightstocker15
nightstocker15 Aug. 22 at 3:48 PM
$VYNE keep pushing bulls! Let’s breakout!!
0 · Reply
OatesTheGoat
OatesTheGoat Aug. 22 at 3:20 PM
$VYNE setting up off bottom of descending wedge
0 · Reply
bochico
bochico Aug. 22 at 2:39 PM
$VYNE c'mon, need more than a couple percent. PUSH!!! 💰💰💰🚀
0 · Reply
Komba
Komba Aug. 22 at 1:26 PM
$VYNE spread of 50% atm 🤣
0 · Reply
Pharma_Stock_Calls
Pharma_Stock_Calls Aug. 22 at 11:50 AM
🚨 New Signal ✅ 💊 $VYNE 🗓️ Aug 22, 2025 🎯 Entry: $0.3228 🎯 Target: $0.3782 (+17.15%)
0 · Reply
Love_To_Learn
Love_To_Learn Aug. 22 at 10:46 AM
$VYNE slowed your movement down masking the sub 0.30 by few days
0 · Reply
nightstocker15
nightstocker15 Aug. 22 at 2:52 AM
$APM had its day today! 💰 Now wake me up to .70 for $VYNE! I’m not greedy 💪💰🐂 Hell, they have more cash per share than that on the books with zero debt! 🤯💰
1 · Reply
karku
karku Aug. 21 at 8:43 PM
0 · Reply
Duskfall
Duskfall Aug. 21 at 7:23 PM
Hold on 💪 $INTS $VYNE
0 · Reply
Duskfall
Duskfall Aug. 21 at 7:17 PM
$VYNE 📈✅
0 · Reply
Komba
Komba Aug. 21 at 6:51 PM
$VYNE load the boat
1 · Reply